Article
Using "residual" FNA rinse and body fluid specimens for next-generation sequencing: An institutional experience.
Cancer cytopathology - 1 May 2016
Wei Shuanzeng, Lieberman David, Morrissette Jennifer J D, Baloch Zubair W, Roth David B, McGrath Cindy
Abstract excerpt
BACKGROUND: Tissue specimens are typically considered optimal for molecular testing; however, in the current era of personalized medicine, cytopathology specimens are increasingly recognized as potential sources for molecular testing. This is often accomplished by using cell block specimens and/or fine-needle aspiration (FNA) smear preparations. In this study, the authors investigated the feasibility,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
